We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pilot: Group Therapy for Children Who Stammer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00945113
Recruitment Status : Completed
First Posted : July 23, 2009
Last Update Posted : October 12, 2015
University of Newcastle Upon-Tyne
North Tyneside Primary Care Trust
Northumberland Care Trust
Information provided by (Responsible Party):
Newcastle-upon-Tyne Hospitals NHS Trust

Brief Summary:

The aim of the study is to answer the question: Is a large-scale research study of the effectiveness of group speech and language therapy (SALT) for young people who stammer possible?

The study will look at the issues involved in setting up a large-scale investigation of treatment for young people who stammer. It will inform the investigators whether larger studies would be possible and give some early-stage information on the effectiveness of group SALT for these young people. The findings will pave the way for building and testing out treatment programmes where there will be clear positive benefit for young people who stammer and their families.

To answer the research question, the study will tell the investigators (a) how easy/difficult it was to get people to take part, (b) young people and parents'/carers' views on taking part and (c) whether the assessments were able to pick up changes in speech and attitudes towards stammering reported by the young people and their carers.

Sufficient numbers of participants were not recruited to carry out the intended rehearsal pilot RCT study design.

Condition or disease Intervention/treatment
Stammering Behavioral: One-week speech therapy group

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: A Pilot Randomised Controlled Trial of the Effectiveness of Intensive Group Speech and Language Therapy as a Treatment for Older Children Who Stammer
Study Start Date : June 2009
Primary Completion Date : October 2009
Study Completion Date : October 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Treatment group
attendance at one-week speech therapy group
Behavioral: One-week speech therapy group
One-week cross-district speech therapy group for older children (aged 8 to 15) who stammer

Primary Outcome Measures :
  1. Overall Assessment of the Speaker's Evaluation of Stuttering (OASES) score [ Time Frame: July 2009 week 2, July 2009 week 4, October 2009 week 4 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Aged between 8;0 years and 15;11 years at 20.07.09
  • Currently in treatment, on review or on waiting list for treatment.
  • Has had an initial NHS Speech and Language Therapy assessment by Newcastle, Northumberland or North Tyneside Speech and Language Therapy service.
  • Has a diagnosis of stammering.
  • Has sufficient understanding of spoken (English) language to score at or above the 16th percentile on the Understanding Linguistic Concepts subtest of the CELF-4UK assessment.
  • Available to attend treatment for the whole week of 20th July 2009
  • Available to attend treatment for the whole week of 24th August 2009

Exclusion Criteria:

  • Diagnosis of Attention and/or Hyperactivity Disorders
  • Diagnosis of moderate or severe general learning difficulties
  • Diagnosis of moderate or severe receptive and/or pragmatic language difficulties
  • Parent/carer for whom an interpreter would be required

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00945113

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle-upon-Tyne, Tyne and Wear, United Kingdom
Sponsors and Collaborators
Newcastle-upon-Tyne Hospitals NHS Trust
University of Newcastle Upon-Tyne
North Tyneside Primary Care Trust
Northumberland Care Trust
Principal Investigator: Lucy E Paterson, MA, BSc Newcastle upon Tyne NHS Hospitals Foundation Trust

Responsible Party: Newcastle-upon-Tyne Hospitals NHS Trust
ClinicalTrials.gov Identifier: NCT00945113     History of Changes
Other Study ID Numbers: 4565
First Posted: July 23, 2009    Key Record Dates
Last Update Posted: October 12, 2015
Last Verified: October 2015

Keywords provided by Newcastle-upon-Tyne Hospitals NHS Trust:
randomised controlled trial
Speech and Language Therapy

Additional relevant MeSH terms:
Speech Disorders
Language Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms